Brian M. Silver - Mar 24, 2022 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role: Chief Financial Officer
Signature: /s/ Brian M. Silver
Stock symbol: TCRX
Transactions as of: Mar 24, 2022
Transactions value $: $50,982
Form type: 4
Date filed: 3/28/2022, 04:31 PM
Previous filing: Jan 20, 2022
Next filing: Jul 27, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCRX	Voting Common Stock	Purchase	$51K	+15K	+126.21%	$3.40	26.9K	Mar 24, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.375 to $3.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.375 to $3.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.